Andrew Witty, UnitedHealth CEO, said the move will remove an excuse other players use to blame Optum Rx for high drug costs.

The Pharmaceutical Care Management Association, which represents PBM's, called the FTC report baseless and "without ...

CVS Health shares are trading lower by 2.7% during Thursday's session. Shares of insurers and pharmacy benefit manager stocks ...

Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...

UnitedHealth reported fourth-quarter results on Thursday that reflected persistent challenges for the health insurance sector ...

UnitedHealth posted a better-than-expected profit in the final quarter of 2024, but revenue fell short as challenges like ...

Garth Reynolds, executive director of the Illinois Pharmacists Association, writes about what he calls a crisis related to ...

The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...

"While this information is theoretically available to the public, institutional owners' holdings are challenging to identify ...

UnitedHealth Group has reported quarterly profits of $5.5 billion after tax in its first earnings release since the killing ...

UnitedHealth’s net income plummeted to its lowest level since 2019 amid hefty costs, including some from the Change ...